Novartis AG Market Cap 2006-2018 | NVS

Novartis AG market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Novartis AG market cap as of November 21, 2018 is $201.5B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $201.503B $49.109B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.911B 18.42
Pfizer (PFE) United States $259.128B 14.61
Merck (MRK) United States $201.621B 17.47
AbbVie (ABBV) United States $132.506B 11.76
Eli Lilly (LLY) United States $121.525B 21.36
Sanofi (SNY) France $112.036B 13.87
Novo Nordisk (NVO) Denmark $106.636B 17.32
AstraZeneca (AZN) United Kingdom $102.177B 12.69
GlaxoSmithKline (GSK) United Kingdom $100.760B 13.54
Bristol-Myers Squibb (BMY) United States $87.355B 14.39